ITP and Immune Hematology Program
ITP and Immune Hematology Program Resources
Treatment Approaches
Guided by rigorous clinical research and the latest international treatment guidelines, our multidisciplinary team provides expert, individualized care for immune-related blood disorders and helps families make informed treatment decisions.
For more information, review the treatment guidelines below. We encourage you to discuss treatment options with our healthcare team and contact us to learn more or become a patient.
| Immune Thrombocytopenia | |
| American Society of Hematology (ASH) 2019 Guidelines |
Evidence-based guidelines to support patients, clinicians, and other health care professionals in their decisions about the management of ITP |
| ITP International Consensus Report |
Guidance on the diagnosis and management of ITP in adults, pregnant women, and children, including quality-of-life considerations |
| Autoimmune Hemolytic Anemia | |
| UpToDate® (brief introduction) |
A physician-authored medical review that discusses the treatment and prognosis of AIHA in children |
| Blood Advances 2026 Pediatric autoimmune hemolytic anemia is associated with a high incidence of underlying immune disorders (abstract) |
A report of the largest study of childhood autoimmune hemolytic anemia to date, highlighting the rarity of the condition and identifying subgroups with genetic predisposition and underlying immune disorders |
| Evans Syndrome | |
| British Journal of Hematology 2016 How I manage Evans Syndrome and AIHA cases in children (abstract) |
A review that summarizes the mechanisms underlying the disease and proposes a clinical approach to diagnosis and treatment, with particular emphasis on the management of relapsed and refractory disease |
| National Organization for Rare Disorders |
A general summary of Evans syndrome, including an overview of the disease, its symptoms, causes, and standard therapies |
| Autoimmune Neutropenia | |
| American Society of Hematology (ASH) 2016 |
This review explains how autoimmune and other acquired neutropenias are diagnosed and managed, discusses common causes, and emphasizes supportive care for conditions that often improve on their own |
| Pediatric Blood & Cancer 2020 The cost of a “benign” condition: Healthcare utilization and infectious outcomes in young children with primary autoimmune neutropenia (abstract) |
A report demonstrating that children with autoimmune neutropenia remained free of confirmed bloodstream infections despite frequent fever-related hospital visits, supporting a less intensive and more cost-effective approach to fever management |
Related Health Topics
Advocacy Organizations
Below, see a list of organizations selected from Beyond Diagnosis that are relevant to immune‑related blood disorders.
American Society of Hematology (ASH)
Scope: Patient education and advocacy, research funding
ITP Consortium of North America (ICON)
Scope: Patient education, research consortium
Jeffrey Modell Foundation
Scope: Patient education and support, research funding
National Bleeding Disorders Foundation
Scope: Patient education and support
National Organization of Rare Disorders (NORD)
Scope: Patient education and support
Platelet Disorder Support Association (PDSA)
Scope: Patient education and support
Patient & Family Support
Explore the comprehensive amenities and resources for families dealing with pediatric cancer or blood disorders
Connect With Our Care Team
If your child may benefit from our care, we’re here to help you take the first step—together with your child’s doctor.